Makwali Judith A, Wanjala Frederick M E, Kaburi Josyline C, Ingonga Johnstone, Byrum Wabwoba W, Anjili Christopher O
School of Science, Department of Biological Sciences, Chepkoilel Campus, Moi University, P.O. Box 1125, Eldoret 30100, Kenya.
J Vector Borne Dis. 2012 Sep;49(3):123-30.
BACKGROUND & OBJECTIVES: Leishmaniasis is a growing health problem in many parts of the world. Efforts to find new chemotherapeutics for leishmaniasis remain a priority. This study was carried out to determine the effect of combination and monotherapies using plant extracts and herbicides on Leishmania major infection in BALB/c mice.
The herbicides and saponin extract were purchased from Sigma. Roots of Plumbago capensis were collected from Karura forest, Nairobi, Kenya. Plant extractions were done in KEMRI at Center for Traditional Medicines and Drugs Research.
Lesion sizes after infection of BALB/c mice were similar in all the experimental groups till the onset of therapeutic treatments (p >0.05). At 15 days post-treatment, significant differences (p < 0.05) were discerned in the lesion sizes of the BALB/c mice in all the mono- and combined-treated groups. However, the combined therapies caused total elimination of the parasites from the lesions and significantly reduced parasite burden in liver and spleen compared to the untreated controls at the end of the experiment.
INTERPRETATION & CONCLUSION: The results of this study demonstrate that combination therapy using alternative administration of saponin, acriflavine, trifluralin and plumbagin is effective in treating L. major infection in mice. In this regard, an investigation into the efficacy of these combined therapies against other Leishmania strains should be explored further. Furthermore, studies with these combination therapies should be done on non-human primates such as the vervet monkey (Cercopithecus aethiops).
利什曼病在世界许多地区正成为一个日益严重的健康问题。寻找治疗利什曼病的新化疗药物仍然是当务之急。本研究旨在确定使用植物提取物和除草剂的联合疗法及单一疗法对BALB/c小鼠体内杜氏利什曼原虫感染的影响。
除草剂和皂苷提取物购自Sigma公司。南非蓝雪的根采自肯尼亚内罗毕的卡鲁拉森林。植物提取物在肯尼亚医学研究协会传统药物研究中心制备。
在开始治疗前,所有实验组感染杜氏利什曼原虫的BALB/c小鼠的病变大小相似(p>0.05)。治疗后15天,所有单一疗法和联合疗法治疗组的BALB/c小鼠病变大小出现显著差异(p<0.05)。然而,与未治疗的对照组相比,联合疗法在实验结束时使病变中的寄生虫完全清除,并显著降低了肝脏和脾脏中的寄生虫负荷。
本研究结果表明,皂苷、吖啶黄素、氟乐灵和白花丹素交替给药的联合疗法对治疗小鼠体内的杜氏利什曼原虫感染有效。在这方面,应进一步研究这些联合疗法对其他利什曼原虫菌株的疗效。此外,应对诸如绿猴(非洲绿猴)等非人类灵长类动物进行这些联合疗法的研究。